By Counterforce Health Team in Krystexxa (pegloticase) —

Renewing Krystexxa (Pegloticase) Coverage with Aetna CVS Health in North Carolina: 2025 Requirements and Timeline

Answer Box: Krystexxa Renewal Quick Guide

Aetna CVS Health requires annual prior authorization renewal for Krystexxa (pegloticase) in North Carolina. Start renewal 2-4 weeks before expiration. Key requirements: serum uric acid levels below 6 mg/dL, documented clinical improvement, and rheumatologist prescribing. If denied, use North Carolina's Smart NC external review program within 120 days. First step today: Check your current approval expiration date and gather recent lab results showing uric acid response.

Table of Contents

  1. When to Start Your Renewal Process
  2. Required Documentation for Renewal
  3. Aetna CVS Health Renewal Criteria
  4. Submission Timeline and Process
  5. If Your Renewal is Denied
  6. Managing Treatment Gaps
  7. 2025 Formulary Changes to Watch
  8. Renewal Tracking Template

When to Start Your Renewal Process

Begin your Krystexxa renewal 2-4 weeks before your current authorization expires. This buffer prevents treatment interruptions that could trigger dangerous flare-ups or require you to restart the approval process entirely.

Renewal Triggers

  • 12-month mark: Most Aetna plans require annual reapproval
  • Two consecutive uric acid levels above 6 mg/dL: Immediate discontinuation required per FDA labeling
  • Formulary changes: Mid-year updates can affect coverage status
  • Plan changes: New insurance year or employer plan modifications
Tip: Set a calendar reminder 6 weeks before expiration to begin gathering documentation.

Required Documentation for Renewal

Your renewal packet must demonstrate ongoing medical necessity and therapeutic response. Missing any key component typically results in automatic denial.

Essential Documents Checklist

Clinical Response Evidence:

  • Recent serum uric acid levels (must be <6 mg/dL before infusions)
  • Documentation of reduced gout flares or tophi improvement
  • Current clinical notes from rheumatologist
  • Infusion logs showing consistent treatment adherence

Prescriber Requirements:

  • Letter from rheumatologist (or nephrologist) confirming ongoing need
  • Updated treatment plan and monitoring schedule
  • Confirmation of G6PD deficiency testing (if not previously documented)

Administrative Items:

  • Completed prior authorization renewal form
  • Current insurance card and member ID
  • Previous approval letter for reference

Medical Necessity Letter Template

Your rheumatologist's renewal letter should address:

  1. Current clinical status: "Patient continues to demonstrate excellent response to pegloticase with serum uric acid maintained below 6 mg/dL"
  2. Ongoing need: "Alternative therapies (allopurinol, febuxostat) remain contraindicated due to [specific reasons]"
  3. Treatment response: "Significant reduction in gout flares from [X] per month to [Y] per month"
  4. Monitoring plan: "Patient will continue bi-weekly infusions with pre-infusion uric acid monitoring"

Aetna CVS Health Renewal Criteria

Based on Aetna's specialty drug policies, Krystexxa renewal requires meeting specific clinical benchmarks.

Requirement Documentation Needed Where to Find
Serum uric acid response Lab reports showing levels <6 mg/dL Recent infusion center records
Clinical improvement Reduced flares, tophi shrinkage Rheumatologist notes
Appropriate prescribing Rheumatologist or nephrologist Provider credentials
Age requirement Patient ≥18 years old Medical records
Failed alternatives Prior trials of allopurinol/febuxostat Treatment history

Key Clinical Benchmarks

Treatment Response Markers:

  • Serum uric acid consistently below 6 mg/dL before infusions
  • Reduction in gout flare frequency or severity
  • Improvement in tophi size or number (if applicable)
  • Maintained functional status

Safety Monitoring:

  • No severe infusion reactions requiring discontinuation
  • Appropriate pre-medication protocols followed
  • Regular monitoring by qualified specialist
Note: If two consecutive pre-infusion uric acid levels exceed 6 mg/dL, Aetna will typically require treatment discontinuation per safety protocols.

Submission Timeline and Process

Standard Renewal Timeline

Weeks 4-6 before expiration:

  • Contact rheumatologist to schedule renewal visit
  • Request updated lab work if needed
  • Begin gathering documentation

Weeks 2-4 before expiration:

  • Submit complete renewal packet
  • Follow up with Aetna to confirm receipt
  • Track submission through member portal

Decision timeframe:

  • Standard review: 30-45 days
  • Expedited review: 72 hours (if urgent medical need)

How to Submit Your Renewal

  1. Online portal: Aetna member portal (fastest option)
  2. Provider submission: Your rheumatologist can submit directly
  3. Phone support: 1-800-CVS-RX-1 for assistance
  4. Fax: Use number on your current approval letter

Counterforce Health specializes in helping patients navigate complex specialty drug renewals like Krystexxa, turning insurance challenges into successful approvals through evidence-backed documentation and targeted appeals.

If Your Renewal is Denied

Don't panic—denials are often reversible with proper documentation. North Carolina residents have strong appeal rights through both Aetna's internal process and the state's external review program.

Aetna Internal Appeals Process

Level 1 - Standard Appeal:

  • Deadline: 180 days from denial notice
  • Timeline: 30-45 days for decision
  • How to file: Online portal or written request
  • Required: Denial letter, additional medical records, provider letter

Level 2 - Expedited Appeal:

  • When to use: Urgent medical need or ongoing treatment
  • Timeline: 72 hours for decision
  • Documentation: Physician attestation of urgency required

North Carolina External Review

If Aetna's internal appeals fail, North Carolina's Smart NC program provides binding external review for medical necessity denials.

Smart NC External Review Process:

  • Eligibility: State-regulated plans (most individual/small group)
  • Deadline: 120 days after final internal denial
  • Timeline: 45 days standard, 72 hours expedited
  • Contact: 1-855-408-1212 (free guidance)
  • Outcome: Binding decision; if approved, Aetna must cover within 3 business days
From our advocates: We've seen many Krystexxa denials overturned at external review when patients provided comprehensive documentation of treatment response and prior therapy failures. The key is showing clear clinical benefit that justifies the high cost.

Managing Treatment Gaps

If your renewal is delayed or denied, never stop Krystexxa abruptly without medical supervision. Treatment interruptions can trigger severe gout flares and complicate future approvals.

Bridge Therapy Options

Temporary measures during gaps:

  • Anti-inflammatory prophylaxis: Continue colchicine or NSAIDs if tolerated
  • Oral urate-lowering therapy: Febuxostat or allopurinol (if previously effective)
  • Flare management: Corticosteroids for acute episodes
  • Lifestyle modifications: Dietary changes, hydration, alcohol limitation

Important safety notes:

  • Stop all oral urate-lowering drugs before restarting Krystexxa
  • Pre-medication protocols are critical for restart infusions
  • Monitor closely for infusion reactions after treatment gaps

Restarting After Interruption

When Krystexxa is reapproved after a gap:

  1. G6PD testing: May need repeat if gap >6 months
  2. Pre-medication: Antihistamines and corticosteroids mandatory
  3. Monitoring: Check uric acid before each infusion
  4. Safety protocols: Ensure infusion facility can manage reactions

2025 Formulary Changes to Watch

Good news: Krystexxa remains covered on Aetna's 2025 specialty drug formulary with no noted tier changes or new restrictions.

What to Monitor

Mid-year updates: Aetna publishes formulary changes in January and July Prior authorization criteria: May become more restrictive for new patients Quantity limits: Could affect dosing flexibility Site of care requirements: May specify infusion center networks

Annual Verification Steps

Each January, confirm:

  • Krystexxa formulary status unchanged
  • Your rheumatologist remains in-network
  • Infusion center covered under plan
  • Copay/coinsurance amounts
  • Any new prior authorization requirements

Renewal Tracking Template

Use this template to stay organized throughout your renewal process:

Personal Renewal Tracker

Current approval expires: ___________

Renewal submission date: ___________

Documents submitted:

  • Updated lab results (date: _______)
  • Rheumatologist letter (date: _______)
  • Prior authorization form (date: _______)
  • Treatment response documentation (date: _______)

Follow-up actions:

  • Portal confirmation received
  • Aetna acknowledgment (date: _______)
  • Decision received (date: _______)
  • Next infusion scheduled (date: _______)

Key contacts:

  • Rheumatologist office: ___________
  • Aetna member services: 1-800-CVS-RX-1
  • Smart NC (if needed): 1-855-408-1212

FAQ: Common Renewal Questions

Q: How long does Aetna CVS Health renewal take in North Carolina? A: Standard renewals take 30-45 days. Start 2-4 weeks before expiration to avoid gaps.

Q: What if my uric acid levels are above 6 mg/dL? A: Two consecutive levels >6 mg/dL typically require treatment discontinuation per safety protocols. Work with your rheumatologist immediately.

Q: Can I request expedited renewal? A: Yes, if there's urgent medical need. Your doctor must document why a delay would jeopardize your health.

Q: What if my rheumatologist leaves the network? A: Find a new in-network rheumatologist quickly, as Aetna requires specialist prescribing for renewals.

Q: Does North Carolina have special protections for specialty drugs? A: Yes, Smart NC external review provides binding decisions for medical necessity denials within 45 days.

When navigating complex specialty drug renewals, Counterforce Health helps patients and providers build compelling cases that turn insurance obstacles into approvals, using evidence-based strategies tailored to each payer's specific requirements.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider and insurance plan documents for the most current requirements. Coverage decisions depend on individual medical circumstances and plan benefits.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.